| Application no. and date | 17777211.8 (espacenet) (Federated) (European Patent Register), 20170921 | | Patent/reg. no. and date | DK/EP 3515418, 20210414 | | Publication date | 20190731 | | Priority no. and date | GB 201616116, 20160922 | | EP pub. no. and date |
EP 3515418 20190731 | | Effective date | | | Applicant/owner | Astrazeneca, AB
151 85 Södertälje, SE | | Applicant ref. no. | 1586836 | | Inventor | FRIGAULT, Melanie Mae, AstraZeneca
35 Gatehouse Drive
Waltham, MA 02451, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/47 (2006.01) , A61K 31/4745 (2006.01) , A61K 31/4985 (2006.01) , A61K 31/53 (2006.01) , A61K 31/5377 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C12Q 1/6886 (2018.01) , G01N 33/48 (2006.01) , G01N 33/574 (2006.01) | | Title | ANVENDELSE AF C-MET-INHIBITORER TIL BEHANDLING AF CANCERE, DER OMFATTER MET-MUTATIONER | | Int. application no. | EP2017073894 | | Int. publication no. | WO2018055029 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
